Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9R0I7

Entry ID Method Resolution Chain Position Source
AF-Q9R0I7-F1 Predicted AlphaFoldDB

44 variants for Q9R0I7

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389249454 74 Q>* No EVA
rs3389258236 101 W>G No EVA
rs3403523261 102 Q>R No EVA
rs3389225199 115 A>S No EVA
rs3389260303 135 G>R No EVA
rs3389243769 155 P>S No EVA
rs3403502937 295 E>V No EVA
rs3389252686 305 P>T No EVA
rs253971380 339 Q>R No EVA
rs3389219334 353 H>Q No EVA
rs3389245710 355 Q>* No EVA
rs52178601 368 G>E No EVA
rs3389249516 378 Q>* No EVA
rs3389210402 410 Q>H No EVA
rs3389265607 434 P>S No EVA
rs3389253543 459 Y>N No EVA
rs3389253486 469 T>N No EVA
rs3389249514 497 M>L No EVA
rs3389260319 537 V>D No EVA
rs3389260364 578 P>S No EVA
rs3389252681 595 P>S No EVA
rs265146298 645 Y>F No EVA
rs3389252741 648 P>S No EVA
rs243895505 679 I>V No EVA
rs3389225259 702 L>M No EVA
rs3413127726 789 P>S No EVA
rs3389243753 795 P>Q No EVA
rs3389249068 797 P>S No EVA
rs251018208 798 P>L No EVA
rs3389260326 842 A>T No EVA
rs3389181849 892 T>S No EVA
rs3389225236 894 K>E No EVA
rs3389248443 915 S>T No EVA
rs236626810 922 A>V No EVA
rs3389225229 973 F>V No EVA
rs3389245741 1041 G>D No EVA
rs3389248363 1110 S>N No EVA
rs3389210379 1153 M>T No EVA
rs3389245725 1162 D>E No EVA
rs3389181787 1165 F>L No EVA
rs3389210339 1200 M>T No EVA
rs3389181780 1236 R>C No EVA
rs3389219301 1279 Y>F No EVA
rs3389265518 1356 I>L No EVA

No associated diseases with Q9R0I7

No regional properties for Q9R0I7

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9R0I7

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Nucleus speckle
  • Migrates to nucleolar caps upon blockage of transcription
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
DNA-binding transcription repressor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II.

2 GO annotations of biological process

Name Definition
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
regulation of telomere maintenance Any process that modulates the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MYPNWGRYGG SSHYPPPPVP PPPPPVALPE ASPGPGYSSS TAPAAPSSSG FMSFREQHLA
70 80 90 100 110 120
QLQQLQQMHQ KQMQCVLQPH HLPPPPLPPP PVMPGGGYGD WQPPPPPMPP PPGPALSYQK
130 140 150 160 170 180
QQQYKHQMIH HQRDGPPGLV PMELESPPES PPVPPGSYMP PSQSYMPPPQ PPPSYYPPSS
190 200 210 220 230 240
AQPYLPPAQP GPSKPQLPPP PSIPSGNKTA IQQEPLESGA KNKTAEQKQA APEPDPSTMT
250 260 270 280 290 300
PQEQQQYWYR QHLLSLQQRT KVHLPGHKKG LVTAKDVPEP IKEEAPGPAA SQVAEPLAAE
310 320 330 340 350 360
KPPLPPPNEE APPPLSPEEP QSEDSEDSED SEEDARFKQL KAIAAHWQAA AAHWQQQQQQ
370 380 390 400 410 420
RVGFQYQGIM QRHTQLQQIL QQYQQVIQHS PHIQTMSLDV QLRHYEMQQQ QFQHLFQDWE
430 440 450 460 470 480
REFQLWEEQL HSYPHKDQLQ EYEKQWKTWQ GHMKATQTYL QEKVNSFQTV KSQYLGNMAM
490 500 510 520 530 540
PPPFVPYSQM PPPLPTMPPP VLPPSLPPPV MPPALPTSIP PPGMPPPVMP PSLPTSVPPP
550 560 570 580 590 600
GMPPSLSSGP PPVLPPPALS SAGSPPVLPP PALPGGPPIL PLPPLSSATP PPGIPPPGAP
610 620 630 640 650 660
QGMPPQLTAP LPPASGSQNS QIPEKPRQAL LPTPVSFGST PPSPYHPPPQ SEQVNSKPLN
670 680 690 700 710 720
KVFSSEQGLG ESSALSQSII AAKDTPVKSG GLLADPPKGS FLEGPRGPRE QKEQLQKLKD
730 740 750 760 770 780
FGSEPQMADH LPPPDSRLQN PSRPGMYPPP GSYRPPPPMG KPPGSIVRPS APPARSSIPM
790 800 810 820 830 840
TRPPVPIPPP PPPPPPPPPP PPVIKSKTSS VKQERWDEDS FFGLWDTNDD QGLNSEFKRD
850 860 870 880 890 900
TATIPSAPVL PPPPVHSSIP PPGPMPMGMP PMSKPPPVQH TVDYGHGRDM PTNKVEQIPY
910 920 930 940 950 960
GERITLRPDP LPERSTFDAD HAGQRDRYDR DRDREPYFDR PSNITDHRDF KRDRETHRDR
970 980 990 1000 1010 1020
DRDRVLDYER DRFDRERRPR DDRNQSYRDK KDHSSSRRGG FDRPSYDRKS DRPPYEGPPM
1030 1040 1050 1060 1070 1080
FGGERRTYPE ERMPLPAPAL GHQPPPVPRV EKKPESKNVD DILKPPGRES RPERIVVIMR
1090 1100 1110 1120 1130 1140
GLPGSGKTHV AKLIRDKEVE FGGPAPRVLS LDDYFIAEVE KEEKDPDSGK KVKKKVMEYE
1150 1160 1170 1180 1190 1200
YEADMEETYR TSMFKTFKKT LDDGFFPFII LDAINDRVRH FDQFWSAAKT KGFEVYLAEM
1210 1220 1230 1240 1250 1260
SADNQTCGKR NIHGRKLKEI NKMAEHWEVA PRHMMRLDIR SLLQDAAIEE VEMEDFDANI
1270 1280 1290 1300 1310 1320
EDQKEEKKDA EEEESELGYI PKSKWEMDTS EAKLDKLDGL RTGTKRKRDW EAIASRMEDY
1330 1340 1350 1360 1370 1380
LQLPDDYETR ASEPGKKRVR WADLEEKKDA DRKRAIGFVV GQTDWEKITD ESGHLAERAL
NRTKYI